KAYNAKLAR (Sinir Sistemi Hastalıkları)


1. Skaper SD, Facci L. Mast cell-glia axis in neuroinflammation and therapeutic potential of the anandamide congener palmitoylethanolamide. Philos Trans R Soc Lond B Biol Sci. 2012; 367:3312-25.

2. Dong H, Zhang X, Qian Y. Mast cells and neuroinflammation. Med Sci Monit Basic Res. 2014; 20:200-6.

3. Kim DY, Jeoung D, Ro JY . Signaling pathways in the activation of mast cells cocultured with astrocytes and colocalization of both cells in experimental allergic encephalomyelitis. J Immunol. 2010; 185:273-83.

4.Yuan H, Zhu X, Zhou S, Chen Q, Zhu X, et al. Role of mast cell activation in inducing microglial cells to release neurotrophin. J Neurosci Res. 2010;  88:1348-54.

5. Zhang S, Zeng X, Yang H, Hu G, He S. Mast cell tryptase induces microglia activation via protease-activated receptor 2 signaling. Cell Physiol Biochem. 2012; 29:931-40.

6. Skaper SD, Giusti P, Facci L . Microglia and mast cells: two tracks on the road to neuroinflammation. FASEB J. 2013; 26:3103-17
7. Hadjivassiliou M, Sanders DD, Aeschlimann DP.Gluten-related disorders: gluten ataxia. Dig Dis. 2015;33:264-8.

8. Hadjivassiliou M, Gibson A, Davies-Jones GA, Lobo AJ, Stephenson TJ, Milford-Ward. A Does cryptic gluten sensitivity play a part in neurological illness? Lancet. 1996; 347(8998):369-71.

9. Bürk K, Bösch S, Müller CA, Melms A, Zühlke C, et al. Sporadic cerebellar ataxia associated with gluten sensitivity. Brain. 2001; 124:1013-9
10. Ihara M, Makino F, Sawada H, Mezaki T, Mizutani K, et al. Gluten sensitivity in Japanese patients with adult-onset cerebellar ataxia. Intern Med. 2006: 45:135-40.

11. Lock RJ, Tengah DP, Williams AJ, Ward JJ, Bingley PJ, et al.Cerebellar ataxia, peripheral neuropathy, “gluten sensitivity” and anti-neuronal autoantibodies. Clin Lab. 2006; 52:589-92.

12. Pellecchia MT, Scala R, Filla A, De Michele G, Ciacci C, Barone P. Idiopathic cerebellar ataxia associated with celiac disease: lack of distinctive neurological features. J Neurol Neurosurg Psychiatry. 1999; 66:32-5.

13. Luostarinen LK, Collin PO, Peräaho MJ, Mäki MJ, Pirttilä TA. Coeliac disease in patients with cerebellar ataxia of unknown origin. Ann Med. 2001; 33:445-9.

14.  Ludvigsson JF, Olsson T, Ekbom A, Montgomery SM. A population-based study of coeliac disease, neurodegenerative and neuroinflammatory diseases. Aliment Pharmacol Ther. 2007; 25:1317-27.

15- Almaguer-Mederos LE, Almira YR, Góngora EM, et al. Antigliadin antibodies in Cuban patients with spinocerebellar ataxia type 2. J Neurol Neurosurg Psychiatry. 2008 Mar;79(3):315-7.

16. Hadjivassiliou M, Boscolo S, Davies-Jones GA,  et al . The humoral response in the pathogenesis of gluten ataxia. Neurology. 2002; 58:1221-6.

17. Hadjivassiliou M, Mäki M, Sanders DS, et al., Autoantibody targeting of brain and intestinal transglutaminase in gluten ataxia.Neurology. 2006 Feb 14;66(3):373-7.

18. Hadjivassiliou M, Aeschlimann P, Strigun A,et al. Aeschlimann Autoantibodies in gluten ataxia recognize a novel neuronal transglutaminase. Ann Neurol. 2008;64:332-43.

19. Sapone A, Bai JC, Ciacci C, et al. Spectrum of gluten-related disorders: consensus on new nomenclature and classification. BMC Med. 2012; 10:13.

20. Mitoma H, Adhikari K, Aeschlimann D,  Et al., Consensus Paper: Neuroimmune Mechanisms of Cerebellar Ataxias. Cerebellum. 2015 Mar 31. [Epub ahead of print]

21. Ghazal FA, Singh S, Yaghi S, Keyrouz SG. Gluten ataxia: an important treatable etiology of sporadic ataxia. Int J Neurosci. 2012; 122:545-6.

22. Diaconu G, Burlea M, Grigore I, Anton DT, Trandafir LM. Celiac disease with neurologic manifestations in children. Rev Med Chir Soc Med Nat Iasi. 2013; 117:88-94.

23. Hadjivassiliou M, Davies-Jones GA, Sanders DS, Grünewald RA. Dietary treatment of gluten ataxia. J Neurol Neurosurg Psychiatry. 2003;74:1221-4.

24. Blaes F. Diagnosis and therapeutic options for peripheral vasculitic neuropathy.Ther Adv Musculoskelet Dis. 2015 Apr;7(2):45-55.

25. Dalakas MC. Pathogenesis of immune-mediated neuropathies. Biochim Biophys Acta. 2015;1852:658-666.

26. Hadjivassiliou M, Grünewald RA, Davies-Jones GA. Gluten sensitivity as a neurological illness. J Neurol Neurosurg Psychiatry. 2002;72:560-3.

27. Hernandez-Lahoz C, Mauri-Capdevila G, Vega-Villar J, Rodrigo L. Neurological disorders associated with gluten sensitivity. Rev Neurol. 2011; 53:287-300.

28. Djuric Z, Kamenov B, Katic V . Celiac disease manifested by polyneuropathy and swollen ankles . World J Gastroenterol. 2007; 13:2636-8.

29. Lurie Y, Landau DA, Pfeffer J, Oren R. Celiac disease diagnosed in the elderly. J Clin Gastroenterol. 2008; 42:59-61.

30. Viader F, Chapon F, Dao T, Rivrain Y, Lechevalier B. Celiac disease in adults revealed by sensory-motor neuropathy . Presse Med. 1995; 24:222-4.

31. Somay G, Cevik DM, Halaç GU, Abut E, Erenoglu NY. Cobalamine deficiency associated with neuropathy and oral mucosal melanosis in untreated gluten-sensitive enteropathy. Indian J Gastroenterol . 2005; 24:120-2.

32. Boskovic A, Stankovic I. Axonal and demyelinating polyneuropathy associated with celiac disease. Indian Pediatr. 2014;51:311-2.

33. Simonati A, Battistella PA, Guariso G, Clementi M, Rizzuto N. Coeliac disease associated with peripheral neuropathy in a child: a case report. Neuropediatrics. 1998; 29:155-8.

34. Souayah N, Chin RL, Brannagan TH, et al. Effect of intravenous immunoglobulin on cerebellar ataxia and neuropathic pain associated with celiac disease. Eur J Neurol. 2008; 15:1300-3.

35. Brannagan TH 3rd, Hays AP, Chin SS, et al. Small-fiber neuropathy/neuronopathy associated with celiac disease: skin biopsy findings. Arch Neurol. 2005;62:1574-8.

36. Hagen EM, Gjerde IO, Vedeler C, Hovdenak N. Neurological diseases associated with celiac disease. Tidsskr Nor Laegeforen. 2000; 120:439-42.

37. Polizzi A, Finocchiaro M, Parano E, Pavone P, Musumeci S, Polizzi A. Recurrent peripheral neuropathy in a girl with celiac disease. J Neurol Neurosurg Psychiatry. 2000; 68:104-5.

38. Kelly JJ. Peripheral neuropathies associated with monoclonal gammopathies of undetermined significance. Rev Neurol Dis. 2008; 5:14-22.

39. Horiuchi I, Kawano Y, Yamasaki K,  et al. Heightened IgE response to mite antigens in inflammatory neuropathies. J Neurol Sci. 1999;  166:77-80.

40. Esposito B, De Santis A, Monteforte R, Baccari GC. Mast cells in Wallerian degeneration: morphologic and ultrastructural changes. J Comp Neurol. 2002 ;445:199-210.

41. Chapman RW, Laidlow JM, Colin-Jones D, Eade OE, Smith CL . Increased prevalence of epilepsy in coeliac disease. Br Med J. 1978; 2(6132):250-1.

42. Labate A, Gambardella A, Messina D,  et al. Silent celiac disease in patients with childhood localization-related epilepsies. Epilepsia. 2001 42:1153-5.

43. Işıkay S, Kocamaz H. Prevalence of celiac disease in children with idiopathic epilepsy in southeast Turkey. Pediatr Neurol. 2014; 50:479-81

44. Ranua J, Luoma K, Auvinen A, et al. Celiac disease-related antibodies in an epilepsy cohort and matched reference population. Epilepsy Behav. 2005; 6:388-92.

45. Gobbi G, Bouquet F, Greco L,  et al. Coeliac disease, epilepsy, and cerebral calcifications. The Italian Working Group on Coeliac Disease and Epilepsy.Lancet. 1992; 340(8817):439-43.

46. Magaudda A, Dalla Bernardina B, De Marco P,  et al. Bilateral occipital calcification, epilepsy and coeliac disease: clinical and neuroimaging features of a new syndrome. J Neurol Neurosurg Psychiatry. 1993; 56:885-9.

47. Essid M, Trabelsi K, Jerbi E,  et al. Villous atrophy and idiopathic epilepsy. Tunis Med. 2003; 81:270-2.

48. Díaz RM, González-Rabelino G, Delfino A . Epilepsy, cerebral calcifications and coeliac disease. The importance of an early diagnosis. Rev Neurol.2005; 40:417-20.

49. Arroyo HA, De Rosa S, Ruggieri V, de Dávila MT, Fejerman N; Argentinean Epilepsy and Celiac Disease Group. Epilepsy, occipital calcifications, and oligosymptomatic celiac disease in childhood. J Child Neurol. 2002;17:800-6.

50. Diaconu G, Burlea M, Grigore I, Anton DT, Trandafir LM. Celiac disease with neurologic manifestations in children. Rev Med Chir Soc Med Nat Iasi. 2013;117:88-94.

51. Bruni O, Dosi C, Luchetti A, Et al. An unusual case of drug-resistant epilepsy in a child with non-celiac gluten sensitivity. J Seizure. 2014;23:674-6.

52. Pelliccia A, Lucarelli S, Frediani T, et al. Partial cryptogenetic epilepsy and food allergy/intolerance. A causal or a chance relationship? Reflections on three clinical cases. Minerva Pediatr. 1999; 51:153-7.

53. Frediani T, Pelliccia A, Aprile A, Ferri E, Lucarelli S. Partial idiopathic epilepsy: recovery after allergen-free diet. Pediatr Med Chir. 2004;26:196-7.

54. Neal EG, Chaffe H, Schwartz RH, Lawson MS, Edwards N,et al. The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurol.2008; 7:500-6.

55. Ketogenic Diet Study Group of the Subspecialty Group of Neurology, the Society of Pediatrics, Chinese Medical Association. Prospective multicenter study on long-term ketogenic diet therapy for intractable childhood epilepsy. Zhonghua Er Ke Za Zhi. 2013;51:276-82.

56. Plata-Salamán CR, Ilyin SE, Turrin NP, et al. Kindling modulates the IL-1beta system, TNF-alpha, TGF-beta1, and neuropeptide mRNAs in specific brain regions. Brain Res Mol Brain Res. 2000;75:248-58.

57. Vezzani A, Moneta D, Richichi C, et al. Functional role of inflammatory cytokines and antiinflammatory molecules in seizures and epileptogenesis. Epilepsia. 2002; 43 Suppl 5:30-5.

58. Samland H, Huitron-Resendiz S, Masliah E, Criado J, Henriksen SJ, Campbell IL. Profound increase in sensitivity to glutamatergic- but not cholinergic agonist-induced seizuresin transgenic mice with astrocyte production of IL-6. J Neurosci Res. 2003; 73:176-87.

59. Ravizza T, Gagliardi B, Noé F, Boer K, Aronica E, Vezzani A. Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiol Dis. 2008;  29:142-60.

60. Choi J, Koh S, Role of brain inflammation in epileptogenesis. Yonsei Med J. 2008; 49:1-18.

61. Skaper SD, Facci L, Giusti P. Mast cells, glia and neuroinflammation: partners in crime? Immunology. 2014;141:314-27.

62. Frediani T, Lucarelli S, Pelliccia A, et al. Allergy and childhood epilepsy: a close relationship? Acta Neurol Scand. 2001; 104:349-52.

63. Silverberg JI, Joks R, Durkin HG. Allergic disease is associated with epilepsy in childhood: a US population-based study. Allergy. 2014;69:95-103.

64. Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol. 2005; 57:67-81.

65. Morgan JT, Chana G, Abramson I, Semendeferi K, Courchesne E, Everall IP. Abnormal microglial-neuronal spatial organization in the dorsolateral prefrontal cortex in autism. Brain Res. 2012;1456:72-81.

66. Zimmerman AW, Jyonouchi H, Comi AM, et al.Cerebrospinal fluid and serum markers of inflammation in autism. Pediatr Neurol. 2005;33:195-201.
67. Theoharides TC, Asadi S, Patel AB (2013) Focal brain inflammation and autism. J Neuroinflammation. 2013; 10:46.

68. Theoharides TC. Is a subtype of autism an allergy of the brain? Clin Ther. 2013;35:584-91.

69. Lyall K, Van de Water J, Ashwood P, Hertz-Picciotto I. Asthma and Allergies in Children With Autism Spectrum Disorders: Results From the CHARGE Study. Autism Res. 2015;8:567-74.

70. Ludvigsson JF, Reichenberg A, Hultman CM, Murray JA. A nationwide study of the association between celiac disease and the risk of autistic spectrum disorders. JAMA Psychiatry. 2013;70:1224-30.

71. Genuis SJ, Bouchard TP. Celiac disease presenting as autism. J Child Neurol. 2010;25:114-9.

72. Sponheim E. Gluten-free diet in infantile autism. A therapeutic trial . Tidsskr Nor Laegeforen. 1991;111:704-7.

73. Knivsberg AM, Reichelt KL, Høien T, Nødland M. A randomised, controlled study of dietary intervention in autistic syndromes. Nutr Neurosci. 2002 5:251-61.

74.Elder JH, Shankar M, Shuster J, Theriaque D, Burns S, Sherrill L. The gluten-free, casein-free diet in autism: results of a preliminary double blind clinical trial. J Autism Dev Disord. 2006;36:413-20.

75. Whiteley P, Haracopos D, Knivsberg AM, et al. The ScanBrit randomised, controlled, single-blind study of a gluten- and casein-free dietary intervention for children with autism spectrum disorders. Nutr Neurosci. 2010; 13:87-100.

76.Pennesi CM, Klein LC. Effectiveness of the gluten-free, casein-free diet for children diagnosed with autism spectrum disorder: based on parental report. Nutr Neurosci. 2012; 15:85-91.

77. Secor VH, Secor WE, Gutekunst CA, Brown MA. Mast cells are essential for early onset and severe disease in a murine model of multiplesclerosis. J Exp Med. 2000; 191:813-22.

78. Brenner T, Soffer D, Shalit M, Levi-Schaffer F. Mast cells in experimental allergic encephalomyelitis: characterization, distribution in the CNS and in vitro activation by myelin basic protein and neuropeptides. J Neurol Sci. 1994;122:210-3.

79. Rozniecki JJ, Hauser SL, Stein M, Lincoln R, Theoharides TC. Elevated mast cell tryptase in cerebrospinal fluid of multiple sclerosis patients. Ann Neurol. 1995;37:63-6.

80.Theoharides TC, Baloyannis SJ, Manolidis LS. Activated rat peritoneal mast cells can cause syngeneic brain demyelination in vitro. Int J Immunopathol Pharmacol. 1991; 4:137–144.

81. Hällgren R, Terent A, Venge P. Eosinophil cationic protein (ECP) in the cerebrospinal fluid. J Neurol Sci. 1983; 58:57-71.

82. Gladue RP, Carroll LA, Milici AJ,  et al. Inhibition of leukotriene B4-receptor interaction suppresses eosinophil infiltration and disease pathology in a murine model of experimental allergic encephalomyelitis. J Exp Med. 1996; 183:1893-8.

83. Sádaba MC, Tzartos J, Paíno C,  et al. Axonal and oligodendrocyte-localized IgM and IgG deposits in MS lesions. J Neuroimmunol, 2012;247:86-94.

84. Huang JT. Serum IgE concentrations in neurological diseases. Ann Allergy. 1975; 34:1-6.

85. Karimi P, Modarresi SZ, Sahraian MA, et al. The relation of multiple sclerosis with allergy and atopy: a case control study. Iran J Allergy Asthma Immunol. 2013;12:182-9.

86. Ashtari F, Jamshidi F, Shoormasti RS, Pourpak Z, Akbari M. Cow’s milk allergy in multiple sclerosis patients. J Res Med Sci. 2013; 18(Suppl 1):S62-5.

87. Reichelt KL, Jensen D. IgA antibodies against gliadin and gluten in multiple sclerosis. Acta Neurol Scand. 2004; 110:239-41.

88. Luis Rodrigo, Carlos Hernández-Lahoz, Et al. Prevalence of celiac disease in multiple sclerosis. BMC Neurol. 2011; 11: 31. Published online 2011 March 7.

89. Pengiran Tengah CD, Lock RJ, Unsworth DJ, Wills AJ. Multiple sclerosis and occult gluten sensitivity. Neurology. 2004; 62:2326-7.

90. Shor DB, Barzilai O, Ram M,  Et al.Gluten sensitivity in multiple sclerosis: experimental myth or clinical truth? Ann N Y Acad Sci. 2009 Sep;1173:343-9.

91. Hewson DC. Is there a role for gluten-free diets in multiple sclerosis? Hum Nutr Appl Nutr.1984; 38:417-20.

92. Rice KM, Walker EM Jr, Wu M, Gillette C, Blough ER Environmental Mercury and Its Toxic Effects. J Prev Med Public Health. 2014; 47:74-83.

93. Attar AM, Kharkhaneh A, Etemadifar M, Keyhanian K, Davoudi V, Saadatnia M Serum mercury level and multiple sclerosis. Biol Trace Elem Res 2012; 146:150-3.

94. Tsai CP, Lee CT Multiple sclerosis incidence associated with the soil lead and arsenic concentrations in Taiwan. 2013; PLoS One. 2013 8:e65911.

95. Hengstman GJ, Wesseling P, Frenken CW, Jongen PJ .Neuromyelitis optica with clinical and histopathological involvement of the brain. Mult Scler . 2007;13:679-82.

96. Lucchinetti CF, Mandler RN, McGavern D, Bruck W, Gleich G, et al. A role for humoral mechanisms in the pathogenesis of Devic’s neuromyelitis optica. Brain . 2002; 125:1450-61.

97. Correale J, Fiol M . Activation of humoral immunity and eosinophils in neuromyelitis optica. Neurology. 2004; 63:2363-70.

98. Zhang H, Verkman AS. Eosinophil pathogenicitiy mechanism and  therapeutics in neuromyelitis optica. J Clin Invest. 2013;123:2306-16.

99. Correale J, Fiol M. Activation of humoral immunity and eosinophils in neuromyelitis optica. Neurology. 2004;63:2363-70.

100.Banati M, Csecsei P, Koszegi E,  et al. Antibody response against gastrointestinal antigens in demyelinating diseases of the central nervous system. Eur J Neurol. 2013; 20:1492-5.

101. Bergamaschi R, Jarius S, Robotti M, Pichiecchio A, Wildemann B, Meola G. Two cases of benign neuromyelitis optica in patients with celiac disease. J Neurol. 2009;256:2097-9.

102. Jacob S, Zarei M, Kenton A,et al. Gluten sensitivity and neuromyelitis optica: two case reports.J Neurol Neurosurg Psychiatry. 2005;76:1028-30.

103. Field EJ, Hughes D.Toxicity of motor neurone disease serum for myelin in tissue culture. British Medical Journal. 1965;5475:1399–1401.

104. Smith RG, Hamilton S, Hofmann F,  et al. Serum antibodies to L-type calcium channels in patients with amyotrophic lateral sclerosis. N Engl J Med. 1992; 327:1721-8.

105. Smith RG, Alexianu ME, Crawford G, et al. Cytotoxicity of immunoglobulins from amyotrophic lateral sclerosis patients on a hybrid motoneuron cell line. Proc Natl Acad Sci U S A. 1994; 91:3393-7.

106. Fratantoni SA, Dubrovsky AL, Uchitel OD. Uptake of immunoglobulin G from amyotrophic lateral sclerosis patients by motor nerve terminals in mice. J Neurol Sci. 1996; 137:97-102.

107. Obál I, Jakab JS, Siklós L, Engelhardt JI . Recruitment of activated microglia cells in the spinal cord of mice by ALS IgG. Neuroreport. 2001;12:2449-52.

108. Engelhardt JI, Siklos L, Appel SH. Altered calcium homeostasis and ultrastructure in motoneurons of mice caused by passively transferred anti-motoneuronal IgG. J Neuropathol Exp Neurol. 1997; 56:21-39.

109. Frakes AE, Ferraiuolo L, Haidet-Phillips AM., et al. Microglia induce motor neuron death via the classical NF-κB pathway in amyotrophic lateral sclerosis. Neuron. 2014;81:1009-23.

110. Appel SH, Zhao W, Beers DR, Henkel JS. The microglial-motoneuron dialogue in ALS. Acta Myol. 2011; 30:4-8.

111. Gordon PH (2013) Amyotrophic Lateral Sclerosis: An update for 2013 Clinical Features, Pathophysiology, Management and Therapeutic Trials. Aging Dis .2013;4:295-310

112. Graves MC, Fiala M, Dinglasan LA,  et al..Inflammation in amyotrophic lateral sclerosis spinal cord and brain is mediated by activated macrophages, mast cells and T cells. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004;5:213-9.

113. Schröder T, Fuchss J, Schneider I., Et al., Eosinophils in hereditary and inflammatory myopathies. Acta Myol. 2013;32:148-53.

114. Turner MR, Goldacre R, Ramagopalan S, Talbot K, Goldacre MJ. Autoimmune disease preceding amyotrophic lateral sclerosis: an epidemiologic study. Neurology. 2013; 81:1222-5.

115. Juntas-Morales R, Pageot N, Corcia P, Camu W. Environmental factors in ALS.Presse Med. 20014;43:549-54.

116-118- Redhe O, Pleva J. Recovery from amyotrophic lateral sclerosis and from allergy after removal of dental amalgam fillings. Int J Risk Saf Med. 1994;4:229-36

117. Brown KJ, Jewells V, Herfarth H, Castillo M. White matter lesions suggestive of amyotrophic lateral sclerosis attributed to celiac disease. AJNR Am J Neuroradiol. 2010;31:880-1.

118. Gadoth A, Nefussy B, Bleiberg M, Et al.,Transglutaminase 6 Antibodies in the Serum of Patients With Amyotrophic Lateral Sclerosis. JAMA Neurol. 2015;72:676-81.

119. Bak V, Spalek P, Petrovajova T, et al. Thymic tumours associated with Myasthenia gravis: a long term observation study of operated patients. Bratisl Lek Listy. 2013; 114:464-8.

120. Malhotra V, Tatke M, Khanna SK, Gondal R . Thymic histology in myasthenia gravis. Indian J Chest Dis Allied Sci.1992; 34:117-21.
121. Halícek F, Rosai J. Histioeosinophilic granulomas in the thymuses of 29 myasthenic patients: a complication of pneumomediastinum. Hum Pathol. 1984;15:1137-44.

122. Murai H, Osoegawa M, Ochi H, Kira J. High frequency of allergic conjunctivitis in myasthenia gravis without thymoma. J Neurol Sci. 2004; 225:27-31.

123. Freeman HJ, Gillett HR, Gillett PM, Oger J (2009) Adult celiac disease with acetylcholine receptor antibody positive myasthenia gravis. World J Gastroenterol. 2009;15:4741-4.

124. Csaplár M, Juhász M, Muzes G, et al. Association of coeliac disease and myasthenia gravis. Orv Hetil. 2006;147:841-4.

125. Meraz-Ríos MA, Toral-Rios D, Franco-Bocanegra D, et al.Inflammatory process in Alzheimer’s Disease. Front Integr Neurosci. 2013;7:59.

126. Kitazawa M, Yamasaki TR, LaFerla FM. Microglia as a potential bridge between the amyloid beta-peptide and tau. Ann N Y Acad Sci. 2004;1035:85-103.

127.Eriksson UK, Gatz M, Dickman PW, Fratiglioni L, Pedersen NL. Asthma, eczema, rhinitis and the risk for dementia. Dement Geriatr Cogn Disord.


128. Rusanen M, Ngandu T, Laatikainen T, et al. Chronic obstructive pulmonary disease and asthma and the risk of mild cognitive impairment and dementia: a population based CAIDE study. Curr Alzheimer Res. 2013; 10:549-55.

129. Sarlus H, Höglund CO, Karshikoff B, et al. Allergy influences the inflammatory status of the brain and enhances tau-phosphorylation. J Cell Mol Med. 2012;16:2401-12.

130. Frisoni GB, Carabellese N, Longhi M, et al. Is celiac disease associated with Alzheimer’s disease? Acta Neurol Scand. 1997;95:147-51.

131. Lee J, Freeman JL. Zebrafish as a model for investigating developmental lead (Pb) neurotoxicity as a risk factor in adult neurodegenerative disease: A mini-review. Neurotoxicology. 20014;43:57-64.

132. Chin-Chan M, Navarro-Yepes J, Quintanilla-Vega B. Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases. Front Cell Neurosci. 2015;9:124.

133. Banati RB, Daniel SE, Blunt SB. Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson’s disease. Mov Disord. 1998; 13:221-7.

134. Bower JH, Maraganore DM, Peterson BJ, Ahlskog JE, Rocca WA. Immunologic diseases, anti-inflammatory drugs, and Parkinson disease: a case-control study. Neurology.  2006;67:494-6.

135. Chen S, Le WD, Xie WJ,  Et al.Experimental destruction of substantia nigra initiated by Parkinson disease immunoglobulins. Arch Neurol. 1998;55:1075-80.

136. Di Lazzaro V, Capone F, Cammarota G, Di Giuda D, Ranieri F.Dramatic improvement of parkinsonian symptoms after gluten-free diet introduction in a patient with silent celiac disease. J Neurol. 2014; 261:443-5.

137. Coon S, Stark A, Peterson E, Gloi A, Kortsha G, et al. Whole-body lifetime occupational lead exposure and risk of Parkinson’s disease. Environ Health Perspect. 2006;114:1872-6.

138. Orange JS, Song LA, Twarog FJ, Schneider LC. A patient with severe black fly (Simuliidae) hypersensitivity referred for evaluation of suspected immunodeficiency. Ann Allergy Asthma Immunol. 2004;92:276-80.

139. Midha V, Jain NP, Sood A, et al. Landry-Guillaine-Barré syndrome as presentation of celiac disease. Indian J Gastroenterol. 2007;26:42-3.
140. Gupta V, Kohli A. Celiac disease associated with recurrent Guillain Barre syndrome. Indian Pediatr. 2010;47:797-8.

141. Cicek D, Halisdemir N, Dertioglu SB, et al. Increased frequency of restless legs syndrome in atopic dermatitis. Clin Exp Dermatol. 2012;37:469-76.

142. Haddad FG, Maalouly GD, Fahed JI, Jammal MH, El Nemnoum RJ. Restless leg syndrome in a patient with celiac disease: a coincidence or an association? Ann Saudi Med. 2009;29:238-9.

143. Manchanda S, Davies CR, Picchietti D. Celiac disease as a possible cause for low serum ferritin in patients with restless legs syndrome. Sleep Med. 2009;10:763-5.

144. Moccia M, Pellecchia MT, Erro R, et al. Restless legs syndrome is a common feature of adult celiac disease. Mov Disord. 2010;25:877-81

145. Weinstock LB, Walters AS, Mullin GE, Duntley SP. Celiac disease is associated with restless legs syndrome. Dig Dis Sci. 2010;55:1667-73.

146. Cikrikcioglu MA, Halac G, Hursitoglu M, Erkal H, Cakirca M, et al (2011) Prevalence of gluten sensitive enteropathy antibodies in restless legs syndrome. Acta Neurol Belg. 2011;111:282-6.

147. Kurihara M, Kumagai K, Nakae Y, Kurihara K. Latex allergy in patients with severe motor and intellectual disabilities syndrome. No To Hattatsu. 2001; 33:241-5.

148. Hosoki K, Suga S, Takahashi J, et al. Prevalence of allergy in patients with severe motor and intellectual disabilities (SMID). Arerugi. 2011; 60:823-33.

149. Stenberg R, Schollin J. Is there a connection between severe cerebral palsy and increased gluten sensitivity? Acta Paediatr. 2007; 96:132-4.

150.Stenberg R, Dahle C, Lindberg E, Schollin J. Increased prevalence of anti-gliadin antibodies and anti-tissue transglutaminase antibodies in children with cerebral palsy. J Pediatr Gastroenterol Nutr. 2009; 49:424-9.

151. Stenberg R, Hadjivassiliou M, Aeschlimann P, Hoggard N, Aeschlimann D. Anti-transglutaminase 6 antibodies in children and young adults with cerebral palsy. Autoimmune Dis. 2014:237107.

152. Stenberg R, Dahle C, Magnuson A, Hellberg D, Tysk C. Increased prevalence of antibodies against dietary proteins in children and young adults withcerebral palsy.J Pediatr Gastroenterol Nutr. 2013;56:233-8.

153. Ng S, Lin CC, Hwang YH, et al. Mercury, APOE, and children’s neurodevelopment. Neurotoxicology. 2013; 37:85-92.

154. Kailin EW, Hastings A. Electromyographic evidence of cerebral malfunction in migraine due to egg allergy. Report of a case. Med Ann Dist Columbia. 1970 ;39:437-41.

155. Grant EC. Food allergies and migraine. Lancet. 1979;1(8123):966-9.

156. Ratner D, Shoshani E, Dubnov B. Milk protein-free diet for nonseasonal asthma and migraine in lactase-deficient patients. Isr J Med Sci. 1983;19:806-9.

157. Heatley RV, Denburg JA, Bayer N, Bienenstock J. Increased plasma histamine levels in migraine patients. Clin Allergy. 1982;12:145-9.

158. Alstadhaug KB. Histamine in migraine and brain. Headache. 2014; 54:246-59.

159. Theoharides TC, Donelan J, Kandere-Grzybowska K, Konstantinidou A. The role of mast cells in migraine pathophysiology. Brain Res Brain Res Rev.2005; 49:65-76.

160. Gazerani P, Pourpak Z, Ahmadiani A, Hemmati A, Kazemnejad A. A correlation between migraine, histamine and immunoglobulin e. Scand J Immunol. 2003; 57:286-90.

161. Muñoz-Jareño N, Fernández-Mayoralas DM, Martínez-Cervell C, Campos-Castelló J Relationship between migraine and atopy in childhood: a retrospective case-control study. Rev Neurol. 2011;53:713-20.

162. Wilson CW, Kirker JG, Warnes H, O’Malley M. The clinical features of migraine as a manifestation of allergic disease. Postgrad Med J. 1980; 56:617-21.

163. Pradalier A, Weinman S, Launay JM, Baron JF, Dry J. Total IgE, specific IgE and prick-tests against foods in common migraine–a prospective study. Cephalalgia. 1983;3:231-4.

164. Dimitrova AK, Ungaro RC, Lebwohl B et al. Prevalence of migraine in patients with celiac disease and inflammatory bowel disease. Headache. 2013;53:344-55.

165 Inaloo S, Dehghani SM, Farzadi F, Haghighat M, Imanieh MH. A comparative study of celiac disease in children with migraine headache and a normal control group. Turk J Gastroenterol. 2011;22:32-5.

166. Gabrielli M, Cremonini F, Fiore G, et al. Association between migraine and Celiac disease: results from a preliminary case-control and therapeutic study. Am J Gastroenterol. 2003; 98:625-9.

167.Riccardi VM. Mast-cell stabilization to decrease neurofibroma growth. Preliminary experience with ketotifen. Arch Dermatol. 1987;123:1011-6.

168. Geller M, Ribeiro MG, Araújo AP, de Oliveira LJ, Nunes FP. Serum IgE levels in neurofibromatosis 1. Int J Immunogenet. 2006;33:111-5.

169. Ogle SK, Rose MM, Wildes CT. Development and implementation of a carboplatin desensitization protocol for children withneurofibromatosis, type 1 and hypersensitivity reactions in an outpatient oncology clinic. J Pediatr Oncol Nurs. 2002;19:122-6.

170. Keleş E, Sapmaz E, Gödekmerdan A. The role of allergy in the etiopathogenesis of idiopathic sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol. 2013;270:1795-801.

171. Leggio L, Cadoni G, D’Angelo C,et al. Coeliac disease and hearing loss: preliminary data on a new possible association. Scand J Gastroenterol. 2007;42:1209-13.

172.Hizli S, Karabulut H, Ozdemir O, Sensorineural hearing loss in pediatric celiac patients. Int J Pediatr Otorhinolaryngol. 2011;75:65-8.

173. Hsu L, Zhu XN, Zhao YS. Immunoglobulin E and circulating immune complexes in endolymphatic hydrops. Ann Otol Rhinol Laryngol. 1990;99(7 Pt 1):535-8.

174. Keles E, Gödekmerdan A, Kalida,et al. Meniere’s disease and allergy: allergens and cytokines. J Laryngol Otol. 2004;118:688-93.

175. Shaver EF Jr. Allergic management of Meniere disease. Arch Otolaryngol. 1975;101:96-9.

176. Derebery MJ. Allergic management of Meniere’s disease: an outcome study. Otolaryngol Head Neck Surg. 2000;122:174-82.

177. Boulassel MR, Alost M, Tomasi JP, Deggouj N, Gersdorff M. No increased serum levels of antifood antibodies in patients with Ménière’s disease. ORL J Otorhinolaryngol Relat Spec. 2001;63:19-24.

178. Weinreich HM, Agrawal Y. The link between allergy and Menière’s disease. Curr Opin Otolaryngol Head Neck Surg. 2014 Feb 26.

179. Di Berardino F, Cesarani A. Gluten sensitivity in Meniere’s disease.Laryngoscope. 2012;122:700-2.

180. Di Berardino F, Filipponi E, Alpini D,et al.  Ménière disease and gluten sensitivity: recovery after a gluten-free diet. Am J Otolaryngol. 2013:34:355-6.

181. Manuck TA, Sheng X, Yoder BA, Varner MW (2014) Correlation between initial neonatal and early childhood outcomes following preterm birth. Am J Obstet Gynecol. 2014;210:426.e1-9.

182. Ai-Ashmawy MA. Prevalence and public health significance of aluminum residues in milk and some dairy products. J Food Sci. 2011;76:T73-6.

183. Krewski D, Yokel RA, Nieboer E, et al.Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide. J Toxicol Environ Health B Crit Rev. 2007; 10(Suppl 1): 1–269.

219. Chen WW, Zhang X, Huang WJ. Role of neuroinflammation in neurodegenerative diseases (Review). Mol Med Rep. 2016;13:3391-6.

220. Laxer KD, Trinka E, Hirsch LJ, et al. The consequences of refractory epilepsy and its treatment. Epilepsy Behav. 2014 Aug;37:59-70.

Hülya Uzunismail hakkında 210 makale
43 yıl aktif olarak çalışmış, bunun yaklaşık son 25 yılını da, gıda-hastalık ilişkisini bulma uğraşına adamış bir iç hastalıkları ve gastroenteroloji uzmanı olarak derlediğim bilgi ve deneyimlerimi, hem doktorlar hem de hastalar için bir kitapta birleştirerek paylaşmak istedim.